Curiel and DeSelm receive grant

David T, Curiel, MD, PhD, and Carl DeSelm, MD, PhD have been awarded a grant through a private donation administered by the Goldman Sachs Foundation for their work entitled “In vivo generation of CAR T-cells for cancer immunotherapy”. They will receive $200,000 for their research over two years.